MYRIAD GENETICS, INC. Proceeds from Income Tax Refunds
MYRIAD GENETICS, INC. (MYGN) reported Proceeds from Income Tax Refunds of $11.70 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIncomeTaxRefunds · last filed 2026-07-31
- MYRIAD GENETICS, INC. proceeds from income tax refunds for the quarter ending 2026-03-31 was $11.70M.
- MYRIAD GENETICS, INC. proceeds from income tax refunds for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- MYRIAD GENETICS, INC. proceeds from income tax refunds for the quarter ending 2022-09-30 was $0.00.
- MYRIAD GENETICS, INC. proceeds from income tax refunds for the quarter ending 2021-12-31 was $100.00K.
- MYRIAD GENETICS, INC. proceeds from income tax refunds for fiscal 2023 was $0.00.
- MYRIAD GENETICS, INC. proceeds from income tax refunds for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- MYRIAD GENETICS, INC. proceeds from income tax refunds for fiscal 2021 was $90.00M.
- MYRIAD GENETICS, INC. proceeds from income tax refunds for fiscal 2020 was $0.00.
| Period end | Proceeds from Income Tax Refunds 3 month | Proceeds from Income Tax Refunds 6 month | Proceeds from Income Tax Refunds 9 month | Proceeds from Income Tax Refunds 12 month |
|---|---|---|---|---|
| 2026-03-31 | $11.70M 10-Q · filed 2026-07-31 | |||
| 2023-12-31 | $0.00 10-K · filed 2024-02-28 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 10-K · filed 2024-02-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-05 | |||
| 2021-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $100.00K derived: sum of 2 quarters · filed 2024-02-28 | $90.00M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $89.90M 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | $89.90M 10-Q · filed 2022-08-05 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-04 | $0.00 10-K · filed 2023-03-01 | ||
| 2019-06-30 | $0.00 10-K · filed 2022-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |